Friday, July 15, 2011

Medicines Patent Pool and Gilead Ink Agreement Making HIV and Hepatitis B Treatment More Available in Developing Countries.

The Medicines Patent Pool Announces
First Licensing Agreement with a Pharmaceutical Company

London, 12 July 2011: Today the Medicines Patent Pool announces its first licenses with a pharmaceutical company, Gilead Sciences, to increase access to HIV and Hepatitis B treatment in developing countries.

pills_full_width_full_width

Photo from Medicines Patent Pool web site

* * *

The Medicines Patent Pool and UNITAID joint press release is available here [pdf], and also posted below.

Questions and answers on the Patent Pool licenses are available here [pdf].

Per the Medicines Patent Pool transparency policy [pdf], the full texts of the licenses are posted below.

The main licensing agreement between the Medicines Patent Pool and Gilead is available here [pdf].

The amended and restated form is available here [pdf].

The form sublicensee agreement is available here [pdf].

Medicines Patent Pool and Gilead Licence Agreement / Current Licences / LICENSING / Home - Medicines Patent Pool